Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LRLRMR
Showing 8 of 22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LARIMAR THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.5M shares of LRMR (LARIMAR THERAPEUTICS INC), worth $4.4M as of 2026-Q2. The position was increased (+180.6% shares). LRMR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.4M

Current Shares

1.5M

Total Value Change

+$4.2M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+180.6%
$4.4M0.0%$3.05
43
2026-Q1
Decreased
519,132
-62.0%
$2.3M0.0%$5.51
0
2025-Q4
Decreased
1.4M
-7.5%
$5.2M0.0%$3.91
0
2025-Q3
Increased
1.5M
+10.6%
$4.8M0.0%$3.38
30
2025-Q2
Increased
1.3M
+207.7%
$3.9M0.0%$3.03
43
2025-Q1
New
434,286
-
$933,7150.0%$2.35
35
2024-Q4
Exited
0
-100.0%
$00.0%$3.91
0
2024-Q3
Increased
38,807
+826.4%
$254,1860.0%$6.57
25

Other major holders of LRMR: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used